tirzepatide pharmaceutical company NICE recommends Lilly's for type 2 diabetes treatment Eli Lilly seeks FDA approval

The rise of GLP-1 medications is reshaping both consumer behavior and employer strategies

Common AEs were nausea (23%), vomiting (6%), diarrhea (6%), constipation (10%), headache (6%), fatigue (8%), abdominal pain (2%), and abdominal bloating (2%)

I no longer feel self-conscious about my neck, and I've regained my perfect jawline." - Victoria Anastasia, 42 years old Victoris, USA

Hold the injector button in for 5 seconds, then pull the pen out of the skin

This Review summarizes the available data about combination immunotherapies in T1DM, particularly addressing their clinical importance.

Explore dosage, safety, and the science behind this new peptide.